CD15, Leu M1 by Immunohistochemistry
Also known as: CD15 IHC
Use
CD15 immunohistochemistry (IHC) is a staining technique used to detect CD15 antigen expression in tissue sections. This method is commonly utilized in the diagnosis and classification of certain types of hematological malignancies, such as Hodgkin's lymphoma and other neoplasms, where the presence of CD15 can be indicative of specific subtypes. The test provides important diagnostic and prognostic information that aids in the determination of the most appropriate treatment plans for patients.
Special Instructions
Not provided.
Limitations
This test is performed as a stain and return (technical) service only. It does not include interpretation of results. The results should be interpreted by a qualified pathologist, taking into consideration the complete clinical context and additional findings. Depleted specimens and specimens submitted with non-representative tissue type are not accepted, which may limit testing if suitable material is unavailable.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
CD15
Protein
LOINC Codes
- 94736-6 - Tissue block ID Spec
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
2 slides
Container
Tissue transport kit (ARUP supply #47808)
Collection Instructions
Formalin fix (10 percent neutral buffered formalin) and paraffin embed specimen. Transport tissue block or 5 unstained (3- to 5-micron thick sections), positively charged slides.
Storage Instructions
Room temperature or refrigerated. Ship in cooled container during summer months.
Causes for Rejection
Depleted specimens. Specimens submitted with non-representative tissue type.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant